MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 44th Annual J.P. Morgan Healthcare Conference, being held January 12-15, 2026, at the Westin St. Francis Hotel in San Francisco. Management will be hosting one-on-one meetings with investors and will be participating in a fireside chat on Wednesday, January 14th at 1:30 p.m. Pacific time.
The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health’s website here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com

| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Oct-28 | |
| Oct-28 | |
| Oct-27 | |
| Oct-26 | |
| Oct-15 |
Labcorp outlays up to $872m to acquire BioReferences laboratory assets
OPK +17.52%
Medical Device Network
|
| Oct-15 | |
| Oct-15 | |
| Oct-15 | |
| Sep-08 | |
| Aug-31 | |
| Aug-13 | |
| Jul-28 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite